CREDIT : REBECCA NOBLE / GETTY IMAGES
MEDICAL SERVICES & DEVICES
Robert F. Kennedy Jr. with US President
Donald Trump
For instance, during the 2022 shortage of Bivona tracheostomy tubes, the FDA worked with manufacturers and raw material suppliers to ensure timely production. This included issuing public safety communications and recommending alternative devices and conservation strategies. Although these measures helped reduce the impact, paediatric patients remained disproportionately affected.
WATCH NOW
FDA’s role in managing drug shortages
OSCR monitors risks, assesses vulnerabilities and works with manufacturers, healthcare providers and government agencies to prevent and mitigate disruptions.
Trump, RFK Jr and the future of FDA supply chain disruptions Political dynamics have added complexity to the FDA’s ability to respond to medical device shortages.
Its efforts include maintaining a real-time medical device shortage list, conducting supply chain impact assessments and using regulatory tools such as the Defence Production Act to secure raw materials and prioritise production.
President Donald Trump’s policies, such as the possible imposition of tariffs on imports, could significantly affect the availability and affordability of medical devices.
89
healthcare-digital.com